Showing results (321-330 of 461) with videos related to
Sort By:
Pageof 47
Stem Cells (Dayton, Ohio)|December 23, 2006
Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxiaEnca Martin-Rendon, Sarah J M Hale, Dacey Ryan, et al.Cancer Research|May 6, 2004
Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell linesRuth L Stephen, Mattias C U Gustafsson, Morag Jarvis, et al.Cancer & Metabolism|February 13, 2024
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina responseCeren Yalaz, Esther Bridges, Nasullah K Alham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2017
A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer PatientsLingjian Yang, Janet Taylor, Amanda Eustace, et al.International Journal of Oncology|July 13, 2005
Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cellsJoachim H Clement, Martin Raida, Jörg Sänger, et al.Cancer Research|February 7, 2002
Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathwayJohn R Griffiths, Paul M J McSheehy, Simon P Robinson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancerSrinivasan Madhusudan, Martin Foster, Sethupathi R Muthuramalingam, et al.Journal of Extracellular Vesicles|March 5, 2023
Accessory ESCRT-III proteins are conserved and selective regulators of Rab11a-exosome formationPauline P Marie, Shih-Jung Fan, John Mason, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcomaBart C Kuenen, Jose Tabernero, Jose Baselga, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumorsSarah A Lowndes, Avril Adams, Anthony Timms, et al.Pageof 47